Virtu Financial LLC Alnylam Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$185.01 - $212.05 $334,498 - $383,386	1,808 New	1,808 $343,000
Q2 2022 Aug 09, 2022	SELL	$120.42 - $169.29 $465,062 - $653,797	-3,862 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$127.18 - $173.91 $565,315 - $773,029	-4,445 Reduced 53.51%	3,862 $631,000
Q4 2021 Feb 17, 2022	BUY	$159.56 - $209.29 $1.33 Million - $1.74 Million	8,307 New	8,307 $1.41 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $524,867 - $642,301	-3,092 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$128.63 - $176.89 $397,723 - $546,943	3,092 New	3,092 $524,000
Q2 2020 Aug 07, 2020	SELL	$104.21 - $156.44 $1.16 Million - $1.74 Million	-11,147 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$74.51 - $124.23 $830,562 - $1.38 Million	11,147 New	11,147 $1.28 Million
Q2 2019 Aug 13, 2019	SELL	$65.86 - $92.79 $244,999 - $345,178	-3,720 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$72.76 - $93.45 $270,667 - $347,634	3,720 New	3,720 $348,000
Q4 2018 Jan 16, 2019	SELL	$62.67 - $88.33 $494,090 - $696,393	-7,884 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $690,007 - $967,130	7,884 New	7,884 $690,000
Q2 2018 Jul 30, 2018	SELL	$88.31 - $107.8 $447,466 - $546,222	-5,067 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$88.31 - $107.8 $389,005 - $474,859	-4,405 Reduced 46.51%	5,067 $499,000
Q1 2018 May 14, 2018	BUY	$115.92 - $148.54 $1.1 Million - $1.41 Million	9,472 New	9,472 $1.13 Million
Q4 2017 Feb 09, 2018	SELL	$114.49 - $139.98 $278,783 - $340,851	-2,435 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$72.53 - $118.27 $176,610 - $287,987	2,435	2,435 $286,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.18 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.2 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.42 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.33 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.25 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account